During the past decade, Struttura Complessa di Oncologia conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Struttura Complessa di Oncologia" are "Kidney Neoplasms" (1 trials) and "Refractory Metastatic Gastric Cancer" (1 trials). Many other conditions were trialed in "Struttura Complessa di Oncologia" in a lesser frequency.

Most popular intervention types in "Struttura Complessa di Oncologia" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Axitinib (AG-013736)" (1 trials), "Placebo" (1 trials), "Sorafenib" (1 trials) and "TAS-102" (1 trials). Other intervention names were less common.

The vast majority of trials in "Struttura Complessa di Oncologia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Struttura Complessa di Oncologia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Struttura Complessa di Oncologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Struttura Complessa di Oncologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".